JULES HAIMOVITZ

Corporate Board Profile

Tech Score: 38/100

← Back to All Directors

Software Technology Evidence

5 mention(s) identify JULES HAIMOVITZ as having software/technology expertise.

Company Filing Date Evidence Reason
Innoviva, Inc. 2018-03-23 Jules Haimovitz has served as a member of our Board of Directors since February 2018. Mr. Haimovitz is currently President of Haimovitz Consulting, Inc. He previously served as a member of the board of directors of Ariad Pharmaceuticals, where he was also a member of the audit committee; Dial Global, Inc., where he was also member of the audit committee; and Imclone Pharmaceuticals, where he served as chairperson of the audit committee. Mr. Haimovitz holds a B.S. and M.A. degree in Mathematics from Brooklyn College. Holds B.S. and M.A. degrees in Mathematics, indicating strong technical and analytical skills relevant to programming.
Innoviva, Inc. 2021-04-02 Mr. Haimovitz holds a B.S. and M.A. degree in Mathematics from Brooklyn College. He holds a B.S. and M.A. degree in Mathematics, which is a relevant technical qualification indicating potential programming or software skills.
Innoviva, Inc. 2022-03-25 Mr. Haimovitz holds a B.S. and M.A. degree in Mathematics from Brooklyn College. Holds B.S. and M.A. degrees in Mathematics, which is a relevant technical qualification indicating potential programming skills.
Innoviva, Inc. 2023-04-28 Mr. Haimovitz holds a B.S. and M.A. degree in Mathematics from Brooklyn College. Mr. Haimovitz has demonstrated leadership in his field, his knowledge of financial and financing matters and his prior board service contributed to our conclusion that he should serve as a director. Mr. Haimovitz holds a B.S. and M.A. degree in Mathematics, which is a relevant technical qualification indicating capability in software or programming.
Innoviva, Inc. 2025-04-08 Mr. Haimovitz holds a B.S. (1971) and M.A. (1974) degree in Mathematics from Brooklyn College. Holds a B.S. and M.A. degree in Mathematics, which is a relevant technical qualification indicating potential programming or software-related skills.

Armata Pharmaceuticals, Inc.

Filing Date Source Excerpt
2021-04-21 Jules Haimovitz has served as a member of our Board of Directors since April 2021. ... Mr. Haimovitz was selected as a director because of his leadership in the field, his knowledge of financial and financing matters and his prior board service, all of which makes him a valued member of the Board of Directors.
2022-03-09 By Order of the Board of Directors, Jules Haimovitz Chairman of the Board of Directors Marina del Rey, California March 9, 2022
2022-10-17 Jules Haimovitz joined the board of directors of Armata Pharmaceuticals in April 2021, and in June 2021 was elected as the Company’s Chairman of the Board. At Innoviva, Inc. (NASDAQ: INVA), a company with a portfolio of royalties that include respiratory assets partnered with Glaxo Group Limited, Mr. Haimovitz has served as a member of the Board of Directors since February 2018 and is currently a member of the Audit Committee, the chair of the Compensation Committee and a member of the Nominating/Corporate Governance Committee. Mr. Haimovitz is currently President of Haimovitz Consulting, Inc. He previously served as a member of the board of directors of Ariad Pharmaceuticals, where he was also a member of its audit committee; Dial Global, Inc., where he was also member of its audit committee; and Imclone Pharmaceuticals, where he served as chairperson of its audit committee. Mr. Haimovitz has also served as Chief Executive Officer or Chief Operating Officer of the following companies: Spelling Entertainment, Inc., King World Productions and VJN, Inc. Mr. Haimovitz holds a B.S. and M.A. degree in Mathematics from Brooklyn College.
2023-08-03 Jules Haimovitz joined the board of directors of Armata Pharmaceuticals in April 2021, and served as the Company’s Chairman of the Board between June 2021 and March 2023. At Innoviva, Inc. (NASDAQ: INVA), a company with a portfolio of royalties that include respiratory assets partnered with Glaxo Group Limited, Mr. Haimovitz has served as a member of the Board of Directors since February 2018 and is currently the chair of the Audit Committee, the chair of the Compensation Committee, a member of the Nominating/Corporate Governance Committee, and a member of the Integration Committee.
2024-04-29 Jules Haimovitz joined the board of directors of Armata Pharmaceuticals in April 2021, and served as the Company’s Chairman of the Board between June 2021 and March 2023. At Innoviva, Inc. (NASDAQ: INVA), Mr. Haimovitz has served as a member of the board of directors since February 2018.

Innoviva, Inc.

Filing Date Source Excerpt
2018-03-23 Jules Haimovitz has served as a member of our Board of Directors since February 2018. Mr. Haimovitz is currently President of Haimovitz Consulting, Inc. He previously served as a member of the board of directors of Ariad Pharmaceuticals, where he was also a member of the audit committee; Dial Global, Inc., where he was also member of the audit committee; and Imclone Pharmaceuticals, where he served as chairperson of the audit committee. Mr. Haimovitz holds a B.S. and M.A. degree in Mathematics from Brooklyn College.
2019-03-13 Mr. Haimovitz holds a B.S. and M.A. degree in Mathematics from Brooklyn College. No mention of programming or software engineering experience.
2020-03-11 Mr. Haimovitz holds a B.S. and M.A. degree in Mathematics from Brooklyn College. No mention of programming or software engineering experience.
2021-04-02 Mr. Haimovitz holds a B.S. and M.A. degree in Mathematics from Brooklyn College.
2022-03-25 Mr. Haimovitz holds a B.S. and M.A. degree in Mathematics from Brooklyn College.
2023-04-28 Mr. Haimovitz holds a B.S. and M.A. degree in Mathematics from Brooklyn College. Mr. Haimovitz has demonstrated leadership in his field, his knowledge of financial and financing matters and his prior board service contributed to our conclusion that he should serve as a director.
2024-04-29 Mr. Haimovitz holds a B.S. and M.A. degree in Mathematics from Brooklyn College. Mr. Haimovitz has demonstrated leadership in his field, his knowledge of financial and financing matters and his prior board service contributed to our conclusion that he should serve as a director.
2025-04-08 Mr. Haimovitz holds a B.S. (1971) and M.A. (1974) degree in Mathematics from Brooklyn College.

Data sourced from SEC filings. Last updated: 2026-02-03